Bristol-Myers Squibb Company (BMY) · page 187 of 197
Uses a combination of qualitative testimonials and quantitative benchmarking (Amgen's 3% improvement) to argue for operational change.
Activist deck · expose_contradiction · expose_contradiction · overcrowded density
Slide locked Sign in to view
Slide schematic 8/10
callout 1/2 paragraph 1/1 quote 3/4 source-note 1/1 title 2/2
2 without position callout 1 · quote 1
calloutquote
Components 10
primary callout paragraph testimonial testimonial testimonial quote source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1